FDA Advisory Committee Conflict of Interest.

Details new FDA regulations under P.L. 110-85, the Food and Drug Administration Amendments Act (FDAAA) of 2007, which contains numerous requirements to minimize conflicts of interest among FDA advisory committee members and to ensure safety of prescription drugs, medical devices, and biologics. Summ...

Full description

Bibliographic Details
Corporate Authors:	Library of Congress. Congressional Research Service, ProQuest (Firm)
Format:	eBook
Language:	English
Published:	[Place of publication not identified] : [publisher not identified], 2009.
Series:	U.S. Congressional Research.
Subjects:	Conflict of interests. Drugs. Executive advisory bodies. Electronic books.
Online Access:	Connect to the full text of this electronic book

Description
Summary:	Details new FDA regulations under P.L. 110-85, the Food and Drug Administration Amendments Act (FDAAA) of 2007, which contains numerous requirements to minimize conflicts of interest among FDA advisory committee members and to ensure safety of prescription drugs, medical devices, and biologics. Summarizes regulations tied to recruitment, defining financial interest, disclosure of candidates interests, member requirements and prohibitions, and issues relating to exceptions to prohibitions; and reviews FDA actions subsequent to the passage of FDAAA.
Item Description:	Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource.
Physical Description:	1 online resource.